文献速递肿瘤 PET/CT

采用2-18F-氟-2-脱氧-D-半乳糖PET/CT测量人体肝脏代谢功能——可重复性与临床潜力

Metabolic liver function in humans measured by 2-18F-fluoro-2-deoxy-D-galactose PET/CT-reproducibility and clinical potential.
PubMed 文献 · EJNMMI Res · 2017-08-29

本研究评估18F-FDGal PET/CT测量肝脏代谢功能的日间变异,比较静态扫描SUV与动态扫描Kmet的相关性,并计算总代谢肝脏体积与总SUV。结果显示Kmet与SUV日间差异均无统计学意义,SUV组内相关系数高于Kmet(0.92-0.97 vs 0.49-0.78),Kmet与SUV呈线性关系;健康受试者平均总SUV为23,840(95%CI 21,609;26,070),显著高于肝硬化患者(P<0.001)。

要点

  • 18F-FDGal PET/CT测量肝脏代谢功能可重复性良好,SUV可替代Kmet进行定量。
  • SUV组内相关系数0.92-0.97,高于Kmet的0.49-0.78。
  • 健康受试者平均总SUV 23,840(95%CI 21,609;26,070),显著高于肝硬化患者(P<0.001)。

核心结论

  • 18F-FDGal PET/CT可重复性良好,SUV可替代Kmet用于肝脏代谢功能定量。
  • 18F-FDGal总SUV是治疗前评估个体患者肝脏代谢功能的有前景工具。

研究设计与样本

  • 四例肝硬化患者和六名健康受试者在15天中位间隔内接受两次18F-FDGal PET/CT扫描以确定日间变异。
  • 利用既往研究中14名受试者的扫描数据和测得的18F-FDGal动脉血浓度检查Kmet与SUV的相关性。
  • 计算Kmet和SUV的区域及全肝值,以及总代谢肝脏体积和总代谢肝脏功能(总SUV,平均SUV乘以总代谢肝脏体积)。

主要发现

  • Kmet或SUV均未发现显著的日间差异。
  • SUV的组内相关系数高于Kmet(0.92-0.97 vs 0.49-0.78)。
  • Kmet与SUV之间的关系呈线性。
  • 总代谢肝脏体积日间变异无统计学意义(中位差值50 mL肝组织;P=0.6)。
  • 健康受试者平均总SUV为23,840(95%CI 21,609;26,070),显著高于患者(P<0.001)。

关键数值与推荐

  • SUV组内相关系数0.92-0.97,Kmet组内相关系数0.49-0.78。
  • 总代谢肝脏体积日间中位差值50 mL肝组织,P=0.6。
  • 健康受试者平均总SUV 23,840(95%CI 21,609;26,070),与患者比较P<0.001。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: PET/CT with the radioactively labelled galactose analogue 2-18F-fluoro-2-deoxy-D-galactose (18F-FDGal) can be used to quantify the hepatic metabolic function and visualise regional metabolic heterogeneity. We determined the day-to-day variation in humans with and without liver disease. Furthermore, we examined whether the standardised uptake value (SUV) of 18F-FDGal from static scans can substitute the hepatic systemic clearance of 18F-FDGal (K met, mL blood/min/mL liver tissue/) quantified from dynamic scans as measure of metabolic function. Four patients with cirrhosis and six healthy subjects underwent two 18F-FDGal PET/CT scans within a median interval of 15 days for determination of day-to-day variation. The correlation between K met and SUV was examined using scan data and measured arterial blood concentrations of 18F-FDGal (blood samples) from 14 subjects from previous studies. Regional and whole-liver values of K met and SUV along with total metabolic liver volume and total metabolic liver function (total SUV, average SUV multiplied by total metabolic liver volume) were calculated. RESULTS: No significant day-to-day differences were found for K met or SUV. SUV had higher intraclass correlation coefficients than K met (0.92-0.97 vs. 0.49-0.78). The relationship between K met and SUV was linear. Total metabolic liver volume had non-significant day-to-day variation (median difference 50 mL liver tissue; P = 0.6). Mean total SUV in healthy subjects was 23,840 (95% CI, 21,609; 26,070), significantly higher than in the patients (P < 0.001). CONCLUSIONS: The reproducibility of 18F-FDGal PET/CT was good and SUV can substitute K met for quantification of hepatic metabolic function. Total SUV of 18F-FDGal is a promising tool for quantification of metabolic liver function in pre-treatment evaluation of individual patients.

来源:EJNMMI Res,查看原文。版权归原作者所有。

引用

  1. Bak-Fredslund KP, Lykke Eriksen P, Munk OL, et al. Metabolic liver function in humans measured by 2-18F-fluoro-2-deoxy-D-galactose PET/CT-reproducibility and clinical potential. EJNMMI Res. 2017. PMID: 28853060. doi:10.1186/s13550-017-0320-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。